找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Clinician’s Manual: Treatment of Hypertension; Third Edition Franz H Messerli Book 2011Latest edition Springer Healthcare Ltd. 2011 Clinica

[復(fù)制鏈接]
樓主: intern
31#
發(fā)表于 2025-3-26 21:02:14 | 只看該作者
32#
發(fā)表于 2025-3-27 04:45:49 | 只看該作者
ce..Includes dozens of clear and informative tables and figures to maximize comprehension..Addresses the most recent?and crucial developments in a very common chronic condition..Gives a comprehensive review of currently available medications and combination therapy..Approximately one billion people
33#
發(fā)表于 2025-3-27 08:26:19 | 只看該作者
Conclusion: The Miscellarian Race, same dose of the same drug or combination, despite the fact that BP is not at goal. Any excuses volunteered by the patient (ie, crowded parking garage, mother-in-law visiting) seem good enough to rationalize that day’s high BP as an exception and delay further therapeutic intervention.
34#
發(fā)表于 2025-3-27 12:52:28 | 只看該作者
35#
發(fā)表于 2025-3-27 16:27:04 | 只看該作者
36#
發(fā)表于 2025-3-27 19:49:54 | 只看該作者
Fashions and fads,ngual application is of no added benefit because what gets into the blood stream is actually what is swallowed. Also, sublingual nifedipine lowers BP in a completely uncontrolled way, and such an abrupt BP drop has been associated with acute MI, stroke and death. Clearly, this is BP cosmetics and should be considered malpractice.
37#
發(fā)表于 2025-3-27 22:32:13 | 只看該作者
38#
發(fā)表于 2025-3-28 05:29:45 | 只看該作者
Evidence-based versus eminence-based therapy,that out of 100 screened patients with isolated systolic hypertension only one was included in the SHEP study and 99 were excluded for one reason or another. Can the evidence derived from 1% of the population be extrapolated to the remaining 99%?
39#
發(fā)表于 2025-3-28 10:14:13 | 只看該作者
https://doi.org/10.1007/978-1-907673-32-0Clinical; Professional; Reference; Cardiology
40#
發(fā)表于 2025-3-28 13:15:21 | 只看該作者
978-1-907673-08-5Springer Healthcare Ltd. 2011
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 04:35
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
青铜峡市| 柯坪县| 南江县| 乌苏市| 无棣县| 古田县| 红安县| 商城县| 浮梁县| 祁连县| 奎屯市| 沐川县| 乾安县| 和硕县| 隆安县| 泽州县| 屏山县| 奈曼旗| 墨脱县| 磴口县| 峨眉山市| 望谟县| 新民市| 龙陵县| 左云县| 连平县| 永登县| 柳林县| 宁陵县| 施秉县| 壤塘县| 湟源县| 永寿县| 墨江| 深泽县| 东台市| 夏津县| 临汾市| 沁阳市| 泗水县| 广丰县|